Showing 3 of 3 recruiting trials for “Atypical chronic myeloid leukemia”
Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
👨⚕️ Uma M Borate, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Aug 2024View details ↗
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →